Variant report

Variant	nsv518470
Chromosome Location	chr2:231018169-231027162
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr2:231023362-231023446	K562	blood:	n/a	n/a
2	BHLHE40	chr2:231024958-231025134	GM12878	blood:	n/a	n/a
3	CBX3	chr2:231023179-231023471	K562	blood:	n/a	n/a
4	CBX3	chr2:231023152-231023575	K562	blood:	n/a	n/a
5	CEBPB	chr2:231025993-231026267	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr2:231024952-231025302	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr2:231025941-231026290	IMR90	lung:	n/a	n/a
8	CEBPB	chr2:231025982-231026182	A549	lung:	n/a	n/a
9	CEBPB	chr2:231025956-231026282	HepG2	liver:	n/a	n/a
10	CEBPZ	chr2:231020341-231020415	HepG2	liver:	n/a	n/a
11	CHD1	chr2:231024649-231025276	IMR90	lung:	n/a	n/a
12	CHD2	chr2:231024774-231025146	H1-hESC	embryonic stem cell:	n/a	n/a
13	CHD2	chr2:231025939-231026063	Hela-S3	cervix:	n/a	n/a
14	CTCF	chr2:231025400-231025550	NHDF-neo	bronchial:	n/a	n/a
15	CTCF	chr2:231024929-231025160	LNCaP	prostate:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
16	CTCF	chr2:231026140-231026290	AG09309	skin:	n/a	n/a
17	CTCF	chr2:231024941-231025131	A549	lung:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
18	CTCF	chr2:231024935-231025193	Kidney_OC	kidney:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
19	CTCF	chr2:231026120-231026270	HMEC	breast:	n/a	n/a
20	CTCF	chr2:231024980-231025130	GM12870	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
21	CTCF	chr2:231024989-231025160	GM13976	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
22	CTCF	chr2:231024980-231025130	BJ	skin:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
23	CTCF	chr2:231024980-231025130	HCPEpiC	choroid plexus:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
24	CTCF	chr2:231024960-231025110	GM12866	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
25	CTCF	chr2:231024960-231025110	HFF-Myc	foreskin:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
26	CTCF	chr2:231025260-231025410	HPF	lung:	n/a	n/a
27	CTCF	chr2:231025000-231025150	GM06990	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
28	CTCF	chr2:231025280-231025430	GM12864	blood:	n/a	n/a
29	CTCF	chr2:231024960-231025110	GM12867	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
30	CTCF	chr2:231025920-231026070	HEEpiC	esophagus:	n/a	n/a
31	CTCF	chr2:231024993-231025228	GM12891	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
32	CTCF	chr2:231024902-231025187	ECC-1	luminal epithelium:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
33	CTCF	chr2:231024989-231025197	MCF-7	breast:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
34	CTCF	chr2:231024940-231025090	HCT-116	colon:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
35	CTCF	chr2:231025000-231025150	AoAF	blood vessel:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
36	CTCF	chr2:231024980-231025130	AG10803	skin:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
37	CTCF	chr2:231025560-231025710	AG09319	gingival:	n/a	n/a
38	CTCF	chr2:231024900-231025050	HA-sp	spinal cord:	n/a	n/a
39	CTCF	chr2:231026100-231026250	NHDF-neo	bronchial:	n/a	n/a
40	CTCF	chr2:231024960-231025110	HMF	breast:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
41	CTCF	chr2:231024961-231025167	SK-N-SH_RA	brain:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
42	CTCF	chr2:231024892-231025180	A549	lung:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
43	CTCF	chr2:231024960-231025110	HCPEpiC	choroid plexus:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
44	CTCF	chr2:231024609-231025320	HCT-116	colon:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231024646-231024659 chr2:231025059-231025069 chr2:231025051-231025072
45	CTCF	chr2:231024980-231025130	GM12864	blood:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
46	CTCF	chr2:231024920-231025070	HUVEC	blood vessel:	n/a	chr2:231025059-231025069
47	CTCF	chr2:231024920-231025070	HEK293	kidney:	n/a	chr2:231025059-231025069
48	CTCF	chr2:231025620-231025770	HCFaa	heart:	n/a	n/a
49	CTCF	chr2:231024980-231025130	HA-sp	spinal cord:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072
50	CTCF	chr2:231024814-231025197	HepG2	liver:	n/a	chr2:231025062-231025071 chr2:231025057-231025073 chr2:231025058-231025071 chr2:231025056-231025074 chr2:231025059-231025069 chr2:231025051-231025072

No.	Distal block	Cell Line	Cell type
1	chr2:230872559..230873386-chr2:231024550..231025144,4	K562	blood:
2	chr2:231018019..231019836-chr2:231022699..231024449,2	MCF-7	breast:
3	chr2:230931515..230932312-chr2:231024624..231025691,3	MCF-7	breast:
4	chr2:231016438..231018368-chr2:231018976..231021680,2	K562	blood:
5	chr2:231016438..231018368-chr2:231018976..231021680,2	K562	blood:
6	chr2:231020225..231023004-chr2:231144034..231146526,2	K562	blood:
7	chr2:230872589..230873492-chr2:231024488..231025490,5	MCF-7	breast:
8	chr2:231017697..231020252-chr2:231024181..231026351,2	K562	blood:
9	chr2:231018752..231022838-chr2:231023461..231026351,3	K562	blood:
10	chr2:231017697..231020252-chr2:231024181..231026351,2	K562	blood:
11	chr2:231018752..231022838-chr2:231023461..231026351,3	K562	blood:
12	chr2:231018019..231019836-chr2:231022699..231024449,2	MCF-7	breast:
13	chr2:230931398..230932313-chr2:231024797..231025421,3	MCF-7	breast:

Variant related genes	Relation type
ENSG00000225963	TF binding region

Extended variants
information (count: 356 )
Associated
traits (count: 61 )

Variant overlapped rSNPs/rCNVs (count:356 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7424288	chr2:231018169-231018170	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs150260213	chr2:231018174-231018175	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs530251839	chr2:231018180-231018181	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs548578783	chr2:231018208-231018209	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs373988394	chr2:231018218-231018219	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs527968105	chr2:231018234-231018235	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs12694843	chr2:231018250-231018251	Enhancers Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
8	rs571062062	chr2:231018258-231018259	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs564714713	chr2:231018300-231018301	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs137884269	chr2:231018419-231018420	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs533434088	chr2:231018439-231018440	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs535201913	chr2:231018480-231018481	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs553350165	chr2:231018569-231018570	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs77755075	chr2:231018571-231018572	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs189741231	chr2:231018600-231018601	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs552765712	chr2:231018604-231018605	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs140794664	chr2:231018672-231018673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs576273254	chr2:231018688-231018689	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs375014729	chr2:231018759-231018760	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs543625393	chr2:231018760-231018761	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs371224233	chr2:231018767-231018768	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs386656107	chr2:231018773-231018774	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs386656108	chr2:231018776-231018777	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs12694844	chr2:231018777-231018778	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs71049633	chr2:231018802-231018803	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs574981056	chr2:231018805-231018806	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs569130744	chr2:231018821-231018822	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs542381069	chr2:231018860-231018861	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs144622508	chr2:231018871-231018872	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs560574557	chr2:231018881-231018882	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs527639687	chr2:231018898-231018899	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs13015610	chr2:231018903-231018904	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs370263023	chr2:231018928-231018929	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs531949249	chr2:231018935-231018936	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs181165198	chr2:231018954-231018955	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs529294429	chr2:231019003-231019004	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs549403264	chr2:231019044-231019045	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs76120221	chr2:231019047-231019048	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs149305890	chr2:231019081-231019082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs79604939	chr2:231019150-231019151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs78084137	chr2:231019151-231019152	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs77577901	chr2:231019162-231019163	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs547050394	chr2:231019163-231019164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs547889776	chr2:231019171-231019172	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs565659883	chr2:231019189-231019190	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs539383832	chr2:231019206-231019207	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs78284334	chr2:231019235-231019236	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs569910927	chr2:231019246-231019247	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs185958268	chr2:231019273-231019274	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs555589603	chr2:231019280-231019281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:61)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
Breast cancer	22522925	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:156 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:231017400-231018200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr2:231018000-231018600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr2:231018000-231019200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
4	chr2:231018000-231020200	Enhancers	Breast Myoepithelial Primary Cells	Breast
5	chr2:231018200-231018400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
6	chr2:231018200-231018600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr2:231018200-231018600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
8	chr2:231018200-231018600	Enhancers	Fetal Intestine Small	intestine
9	chr2:231018200-231018800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
10	chr2:231018200-231022600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
11	chr2:231018200-231026000	Weak transcription	Primary T cells from cord blood	blood
12	chr2:231018600-231019000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr2:231018600-231019600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr2:231019000-231019200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr2:231019000-231019800	Enhancers	Placenta	Placenta
16	chr2:231019000-231022400	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr2:231019200-231020000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr2:231019200-231020200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
19	chr2:231019200-231022800	Enhancers	Primary hematopoietic stem cells	blood
20	chr2:231019400-231020600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr2:231019400-231024600	Weak transcription	Brain Inferior Temporal Lobe	brain
22	chr2:231019600-231020400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
23	chr2:231019600-231020600	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr2:231019800-231020600	Enhancers	Monocytes-CD14+_RO01746	blood
25	chr2:231020000-231020400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
26	chr2:231020200-231020400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
27	chr2:231020200-231020400	Enhancers	Primary neutrophils fromperipheralblood	blood
28	chr2:231020200-231021200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
29	chr2:231020400-231021600	Weak transcription	Primary neutrophils fromperipheralblood	blood
30	chr2:231020400-231022600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr2:231020600-231021000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
32	chr2:231020600-231028400	Weak transcription	Monocytes-CD14+_RO01746	blood
33	chr2:231021000-231022400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr2:231021200-231022400	Enhancers	Breast Myoepithelial Primary Cells	Breast
35	chr2:231021600-231022800	Enhancers	Primary neutrophils fromperipheralblood	blood
36	chr2:231022000-231022400	Enhancers	GM12878-XiMat	blood
37	chr2:231022400-231022800	Weak transcription	GM12878-XiMat	blood
38	chr2:231022400-231024800	Weak transcription	Spleen	Spleen
39	chr2:231022400-231029200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
40	chr2:231022600-231023200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr2:231022600-231024600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr2:231022800-231023000	Enhancers	GM12878-XiMat	blood
43	chr2:231022800-231024600	Weak transcription	Primary hematopoietic stem cells	blood
44	chr2:231022800-231024800	Weak transcription	Primary neutrophils fromperipheralblood	blood
45	chr2:231023000-231029000	Weak transcription	GM12878-XiMat	blood
46	chr2:231023600-231030000	Weak transcription	Primary monocytes fromperipheralblood	blood
47	chr2:231023600-231032200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr2:231024400-231024600	Enhancers	Brain Hippocampus Middle	brain
49	chr2:231024400-231025000	Enhancers	Lung	lung
50	chr2:231024600-231024800	Enhancers	Colon Smooth Muscle	Colon

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links